Search Results - "Beyer, Carl F"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3

    microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties by Beyer, Carl F, Zhang, Nan, Hernandez, Richard, Vitale, Danielle, Nguyen, Thai, Ayral-Kaloustian, Semiramis, Gibbons, James J

    Published in Cancer chemotherapy and pharmacology (01-09-2009)
    “…Purpose To compare TTI-237 (5-chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-[1, 2,…”
    Get full text
    Journal Article
  4. 4

    TTI-237 : A Novel Microtubule-Active Compound with In vivo Antitumor Activity by BEYER, Carl F, NAN ZHANG, HERNANDEZ, Richard, VITALE, Danielle, LUCAS, Judy, NGUYEN, Thai, DISCAFANI, Carolyn, AYRAL-KALOUSTIAN, Semiramis, GIBBONS, James J

    Published in Cancer research (Chicago, Ill.) (01-04-2008)
    “…5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine butanedioate…”
    Get full text
    Journal Article
  5. 5

    An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker by Hamann, Philip R, Hinman, Lois M, Beyer, Carl F, Lindh, Delores, Upeslacis, Janis, Flowers, David A, Bernstein, Irwin

    Published in Bioconjugate chemistry (01-01-2002)
    “…The anti-CD33 antibody, P67.6, has been chosen to target the potently cytotoxic calicheamicin antitumor antibiotics to acute myeloid leukemia (AML) due to the…”
    Get full text
    Journal Article
  6. 6

    An Anti-MUC1 Antibody−Calicheamicin Conjugate for Treatment of Solid Tumors. Choice of Linker and Overcoming Drug Resistance by Hamann, Philip R, Hinman, Lois M, Beyer, Carl F, Greenberger, Lee M, Lin, Clara, Lindh, Delores, Menendez, Ana T, Wallace, Rosalyn, Durr, Frederick E, Upeslacis, Janis

    Published in Bioconjugate chemistry (01-03-2005)
    “…The anti-MUC1 antibody, CTM01, has been chosen to target the potently cytotoxic calicheamicin antitumor antibiotics to solid tumors of epithelial origin that…”
    Get full text
    Journal Article
  7. 7

    A Calicheamicin Conjugate with a Fully Humanized Anti-MUC1 Antibody Shows Potent Antitumor Effects in Breast and Ovarian Tumor Xenografts by Hamann, Philip R, Hinman, Lois M, Beyer, Carl F, Lindh, Delores, Upeslacis, Janis, Shochat, Dan, Mountain, Andrew

    Published in Bioconjugate chemistry (01-03-2005)
    “…Murine CTM01 is an internalizing murine IgG1 monoclonal antibody that recognizes the MUC1 antigen expressed on many solid tumors of epithelial origin…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A 'dot-immunobinding assay' on nitrocellulose membrane for the determination of the immunoglobulin class of mouse monoclonal antibodies by Beyer, C F

    Published in Journal of immunological methods (24-02-1984)
    “…A rapid and convenient procedure for the determination of the immunoglobulin class of mouse monoclonal antibodies is described. Hybridoma supernatants or other…”
    Get more information
    Journal Article
  10. 10

    Studies of individual amino acid residues of the decapeptide tyrocidine A by proton double-resonance difference spectroscopy in the correlation mode by Gibbons, William A, Beyer, Carl F, Dadok, Josef, Sprecher, Richard F, Wyssbrod, Herman R

    Published in Biochemistry (Easton) (01-01-1975)
    “…The cyclic decapeptide antibiotic tyrocidine A was studied by two relatively new methods, viz., correlation proton magnetic resonance (pmr) spectroscopy and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Heterogeneous Tryptophan Environments in the Cyclic Peptides Tyrocidines B and C by Beyer, Carl F., Gibbons, William A., Craig, Lyman C., Longworth, James W.

    Published in The Journal of biological chemistry (25-05-1974)
    “…Phosphorescence spectroscopy has been used to probe the microenvironments of the tryptophan residues of the cyclic antibiotic decapeptides tyrocidine B (which…”
    Get full text
    Journal Article
  13. 13

    Lymphocyte Transformation Induced by Chemical Modification of Membrane Components by Beyer, Carl F., Bowers, William E.

    Published in The Journal of immunology (1950) (01-11-1978)
    “…Abstract Neuraminidase treatment of responder cells in indirect periodate or indirect neuraminidase-galactose oxidase (NGO) stimulation of rat lymph node cells…”
    Get full text
    Journal Article
  14. 14

    Rat Dendritic Cells Function as Accessory Cells and Control the Production of a Soluble Factor Required for Mitogenic Responses of T Lymphocytes by Wolfgang E. F. Klinkert, LaBadie, Jon H., O'Brien, James P., Beyer, Carl F., Bowers, William E.

    “…Transformation of T lymphocytes, induced by treatment with periodate or with neuraminidase plus galactose oxidase, requires the participation of accessory…”
    Get full text
    Journal Article
  15. 15

    Lymphocyte Transformation Induced by Chemical Modification of Membrane Components by Beyer, Carl F., Bowers, William E.

    Published in The Journal of immunology (1950) (01-12-1977)
    “…Abstract Reliable culture conditions and a valid 3H-thymidine labeling procedure were established for studies on the in vitro response of rat lymph node cells…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Periodate and Concanavalin A Induce Blast Transformation of Rat Lymphocytes by an Indirect Mechanism by Beyer, Carl F., Bowers, William E.

    “…When rat lymph node cells, rendered incapable of division by treatment with mitomycin C, were then reacted with sodium metaperiodate (NaIO4), they stimulated…”
    Get full text
    Journal Article
  19. 19